WANG YULUN 4
4 · Teladoc Health, Inc. · Filed Jan 27, 2021
Insider Transaction Report
Form 4
WANG YULUN
Head of Research & Development
Transactions
- Sale
Common Stock
[F1]2021-01-25$280.00/sh−8,261$2,313,080→ 219,507 total(indirect: By Trust)
Footnotes (1)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on December 14, 2020.
Signature
/s/ Adam C. Vandervoort, attorney-in-fact|2021-01-27